<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03503578</url>
  </required_header>
  <id_info>
    <org_study_id>2014P000111</org_study_id>
    <nct_id>NCT03503578</nct_id>
  </id_info>
  <brief_title>EEG Studies of Sevoflurane-Induced General Anesthesia</brief_title>
  <official_title>Electroencephalogram Studies of Induction and Recovery From Sevoflurane-Induced General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are performing this research study to find out how and where the anesthetic
      drugs sevoflurane and ketamine act in the brain. Sevoflurane and ketamine are anesthetics (a
      drug or agent used to decrease or eliminate the feeling of pain by causing unconsciousness).
      The investigators will study the brain using a machine that records the brain's electrical
      activity, called an electroencephalogram (EEG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During this research study, participants will receive sevoflurane, and sevoflurane and
      ketamine together, at a high enough dose to induce general anesthesia (make study
      participants &quot;fall asleep&quot;). During one visit participants will receive only sevoflurane;
      during another visit participants will be given both sevoflurane and ketamine together. The
      investigators will record EEG the entire time. The investigators will also ask some questions
      related to pain and cognitive function.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in multitaper spectral estimates of EEG power during sevoflurane-induced general anesthesia.</measure>
    <time_frame>Approximately 60 minutes</time_frame>
    <description>Change from baseline in multitaper spectral estimates of EEG power at sevoflurane-induced loss of responsiveness.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>EEG Dynamics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EEG data will be collected on patients receiving sevoflurane, and sevoflurane and ketamine together.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Subjects will received sevoflurane for approximately 60 minutes.</description>
    <arm_group_label>EEG Dynamics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Subjects will received sevoflurane and ketamine for approximately 60 minutes.</description>
    <arm_group_label>EEG Dynamics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the ages of 18 and 50

          -  Normal body weight and habitus, BMI â‰¤ 30

          -  Non-smoker

          -  American Society of Anesthesiologists (ASA) physical status classification P1

        Exclusion Criteria:

          -  Chronic health conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2018</study_first_submitted>
  <study_first_submitted_qc>April 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Oluwaseun Johnson-Akeju, MD, MMSc</investigator_full_name>
    <investigator_title>Associate Professor of Anaesthesia</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

